<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8"><gtr:id>3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8</gtr:id><gtr:name>Stanford University</gtr:name><gtr:address><gtr:line1>450 Serra Mall</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8"><gtr:id>3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8</gtr:id><gtr:name>Stanford University</gtr:name><gtr:address><gtr:line1>450 Serra Mall</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/57B0D7AD-CD96-4AB2-855B-6398D8F9CC9A"><gtr:id>57B0D7AD-CD96-4AB2-855B-6398D8F9CC9A</gtr:id><gtr:firstName>Marcus</gtr:firstName><gtr:surname>Fruttiger</gtr:surname><gtr:orcidId>0000-0002-6962-5485</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0501711"><gtr:id>09F1EC07-B192-4CDA-B20B-4214CD85E148</gtr:id><gtr:title>Molecular basis of artery vein differentiation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501711</gtr:grantReference><gtr:abstractText>Understanding the mechanisms that control growth and differentiation of blood vessels has important clinical implications. For example, abnormal vascular growth in the retina is a major complication in diseases such as diabetic retinopathy or age related macular degeneration and is the leading cause of blindness in the Western world. However, therapeutic intervention can only be achieved if we fully understand the biological principles of vascular development. Progress has been made in the last decade and some of the basic stop-and-go signals of vessel growth have been identified, but the mechanisms that lead to the complexity and diversity of a fully differentiated vascular tree are not well understood. 

In this project we investigate how vessels differentiate into arteries or veins. To this end we use mice that have conditional mutations in certain genes, suspected to play a role in this process. The mutations can be activated with a drug (tamoxifen) allowing us to study the function of these genes at specific time points during development. This will help us to understand why the two vessel types behave differently during development and under pathological conditions. Such knowledge will form the basis for future therapies that target only specific blood vessel types and might allow us to manipulate the shape of the vascular tree.</gtr:abstractText><gtr:technicalSummary>The vasculature is a highly organized and complex structure on which each and every cell in the body depends. During development, primitive blood vessels form initially simple plexuses that subsequently remodel and differentiate into mature networks consisting of arteries, veins and capillaries. Understanding the molecular mechanisms that guide this process is highly relevant for therapeutic angiogenesis as well as for antiangiogenic therapy. Recent studies in zebrafish have shown that signaling via Notch and vascular endothelial growth factor (VEGF) plays a role in dorsal aorta and cardinal vein formation (the first vessels to develop), but the factors that control artery vein (AV) differentiation later in development are less well understood. A number of genes, suspected to play a role in AV differentiation, have been knocked out in mice but these experiments suffer from the problem that mutations affecting the vasculature usually lead to early embryonic death precluding the study of vascular differentiation in older animals. Here we address this problem by applying an inducible gene deletion method. We recently created mice that express tamoxifen-inducible Cre recombinase specifically in endothelial cells. When they are crossed with mice that contain loxP sites in a particular gene, tamoxifen injection will delete this gene. Preliminary tests have shown that we can target close to 100% of endothelial cells in postnatal animals. We intend to use this system to delete four different genes, involved in Notch and VEGF signaling. We will address the role of VEGF signaling in AV differentiation by deleting VEGF receptor 2 (VEGFR2) and the artery specific VEGF co-receptor Neuropilin-1. We will also study notch signaling (believed to be downstream of VEGF in AV differentiation) by deleting the artery specific notch ligand Delta-like-4 (Dll4). Furthermore, we have previously found evidence that oxygen levels can influence Dll4 expression in arteries and we will therefore target oxygen sensing in arteries by deleting the von-Hippel-Lindau gene. In summary we aim to establish the role of these four genes in postnatal artery vein differentiation but also possible genetic interactions between them.</gtr:technicalSummary><gtr:fund><gtr:end>2009-09-10</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-09-11</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>364147</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London (QMUL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts and The London School of Medicine and Dentistry</gtr:department><gtr:description>Role of cell adhesion signalling in retinal vessel development</gtr:description><gtr:id>F8270C54-22D2-44EA-8D8F-AFDC75CFFA94</gtr:id><gtr:impact>20339539</gtr:impact><gtr:partnerContribution>The collaboration has helped us to rule out some of the genes we suspected to be involved in artery vein differentiation in the retina.</gtr:partnerContribution><gtr:piContribution>We processed and analysed the retinas from mice that were bred by our collaborators.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK (CRUK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Role of jagged1 in angiogenesis</gtr:description><gtr:id>906CA67A-0103-4C3B-AC71-F8727F1117F1</gtr:id><gtr:impact>19524514</gtr:impact><gtr:partnerContribution>providing of mutant mice</gtr:partnerContribution><gtr:piContribution>We provided our collaborators with endothelial-specific tamoxifen-inucible Cre mice and they provided us with mice containing a floxed Dll4 allele. The first part of this work has been published, the second part is still in preparation.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Institute for Heart and Lung Research</gtr:department><gtr:description>EC metabolism</gtr:description><gtr:id>E39991FD-C8B7-4AAE-8DAD-5A9254126717</gtr:id><gtr:impact>Manuscript under submission</gtr:impact><gtr:partnerContribution>Used our strain in combination with other mouse strains to study endothelial cell metabolism during angiogenesis</gtr:partnerContribution><gtr:piContribution>supplied transgenic mouse strain and helped write manuscript</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Stanford University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>CNS vascular development</gtr:description><gtr:id>222EC810-39B6-4996-B417-6C9BDF27BBC8</gtr:id><gtr:impact>21071672</gtr:impact><gtr:piContribution>We provided transgenic mice that allow the genetic targeting of the developing CNS vasculature.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>These mutant mice allow the inducible deletion of specific genes specifically in the vasculature. They have been developed and characterized in parts during this grant.</gtr:description><gtr:id>AA19FD61-6981-46F0-A169-762C9E2DC03D</gtr:id><gtr:impact>The mice have been sent so far to more than 15 labs all of which are still in the process of obtaining data with them. As more and more collaborators are using them the reputation for how well the mice are working is increasing and we are getting an increasing number of requests for them.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Pdgfb-CreER mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/84C8FD58-7286-4410-9FC1-3D0041B67368"><gtr:id>84C8FD58-7286-4410-9FC1-3D0041B67368</gtr:id><gtr:title>Crim1 maintains retinal vascular stability during development by regulating endothelial cell Vegfa autocrine signaling.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/37ad799231b424d365985882911e79fe"><gtr:id>37ad799231b424d365985882911e79fe</gtr:id><gtr:otherNames>Fan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A2F9533A-D162-4CFB-9B3F-3A107CCF49CA"><gtr:id>A2F9533A-D162-4CFB-9B3F-3A107CCF49CA</gtr:id><gtr:title>Efficient, inducible Cre-recombinase activation in vascular endothelium.</gtr:title><gtr:parentPublicationTitle>Genesis (New York, N.Y. : 2000)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/309355c9a4d935157e669a63f7e382d3"><gtr:id>309355c9a4d935157e669a63f7e382d3</gtr:id><gtr:otherNames>Claxton S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1526-954X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/927ED97C-420D-4B07-A262-8E229FD6A3AE"><gtr:id>927ED97C-420D-4B07-A262-8E229FD6A3AE</gtr:id><gtr:title>SRF selectively controls tip cell invasive behavior in angiogenesis.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ae9fda7debb8eac6ef545c44d686a511"><gtr:id>ae9fda7debb8eac6ef545c44d686a511</gtr:id><gtr:otherNames>Franco CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A047FB6A-F429-40DC-A2C7-F846CA937951"><gtr:id>A047FB6A-F429-40DC-A2C7-F846CA937951</gtr:id><gtr:title>Endothelial FAK is required for tumour angiogenesis.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/678080c2bc9979d4354d26836d0a6212"><gtr:id>678080c2bc9979d4354d26836d0a6212</gtr:id><gtr:otherNames>Tavora B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EBAF0C0E-8402-4949-AE5F-1AD64C894B4C"><gtr:id>EBAF0C0E-8402-4949-AE5F-1AD64C894B4C</gtr:id><gtr:title>NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86e60af15e937832c33be867a2917416"><gtr:id>86e60af15e937832c33be867a2917416</gtr:id><gtr:otherNames>Fantin A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B69EBCAD-D649-41F2-BEB7-76A38133E846"><gtr:id>B69EBCAD-D649-41F2-BEB7-76A38133E846</gtr:id><gtr:title>Selective deletion of the endothelial sphingosine-1-phosphate 1 receptor exacerbates kidney ischemia-reperfusion injury.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9b7c4cda8e465d333ba90faedb8a2faa"><gtr:id>9b7c4cda8e465d333ba90faedb8a2faa</gtr:id><gtr:otherNames>Ham A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C2C40865-76B3-4F64-918B-8D13424AE8BF"><gtr:id>C2C40865-76B3-4F64-918B-8D13424AE8BF</gtr:id><gtr:title>The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fad3b4b462a7f5fe66329e5f6950d68a"><gtr:id>fad3b4b462a7f5fe66329e5f6950d68a</gtr:id><gtr:otherNames>Benedito R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0B206F93-B5FE-40B0-B15B-DA7A481C35FA"><gtr:id>0B206F93-B5FE-40B0-B15B-DA7A481C35FA</gtr:id><gtr:title>Survivin-induced abnormal ploidy contributes to cystic kidney and aneurysm formation.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0568ac8fdacb3857d33e33ef11e91ceb"><gtr:id>0568ac8fdacb3857d33e33ef11e91ceb</gtr:id><gtr:otherNames>Aboualaiwi WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A035D4AB-6747-43E3-B758-7080DE6A01D1"><gtr:id>A035D4AB-6747-43E3-B758-7080DE6A01D1</gtr:id><gtr:title>A crucial role for CDC42 in senescence-associated inflammation and atherosclerosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd2f3548a20b525d2054461c47485fd6"><gtr:id>fd2f3548a20b525d2054461c47485fd6</gtr:id><gtr:otherNames>Ito TK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B863E8FB-C52F-465F-9463-6C1CE0D6020D"><gtr:id>B863E8FB-C52F-465F-9463-6C1CE0D6020D</gtr:id><gtr:title>Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c05ceb2d54760bad5e86c07fb4e4b8b0"><gtr:id>c05ceb2d54760bad5e86c07fb4e4b8b0</gtr:id><gtr:otherNames>Kuhnert F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7931A87C-DDA9-4118-A28E-33AA415486D6"><gtr:id>7931A87C-DDA9-4118-A28E-33AA415486D6</gtr:id><gtr:title>cKit Lineage Hemogenic Endothelium-Derived Cells Contribute to Mesenteric Lymphatic Vessels.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14c018d7912e6bd79dc20bf8f867cb30"><gtr:id>14c018d7912e6bd79dc20bf8f867cb30</gtr:id><gtr:otherNames>Stanczuk L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/64215F44-C120-4260-89CE-401EE28F5F2F"><gtr:id>64215F44-C120-4260-89CE-401EE28F5F2F</gtr:id><gtr:title>Acute depletion of endothelial ?3-integrin transiently inhibits tumor growth and angiogenesis in mice.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6c0d956ec0ed62e2d1dc9e8cb3db81b9"><gtr:id>6c0d956ec0ed62e2d1dc9e8cb3db81b9</gtr:id><gtr:otherNames>Steri V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0D16716A-9A39-4D49-9A53-288834AB09B8"><gtr:id>0D16716A-9A39-4D49-9A53-288834AB09B8</gtr:id><gtr:title>VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0a6d8c4c3c6edb232e3f57cf7ef89bd5"><gtr:id>0a6d8c4c3c6edb232e3f57cf7ef89bd5</gtr:id><gtr:otherNames>Tammela T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A0891E3D-6B23-4ADF-8DE5-574D3B862BE7"><gtr:id>A0891E3D-6B23-4ADF-8DE5-574D3B862BE7</gtr:id><gtr:title>FOXO1 couples metabolic activity and growth state in the vascular endothelium.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b5e91183996db6a00797023646128946"><gtr:id>b5e91183996db6a00797023646128946</gtr:id><gtr:otherNames>Wilhelm K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F2352236-8DDB-4A06-A3D6-19659408A48E"><gtr:id>F2352236-8DDB-4A06-A3D6-19659408A48E</gtr:id><gtr:title>Endothelial Wnt/?-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f9abd2fa22b0119898c47b98e0800445"><gtr:id>f9abd2fa22b0119898c47b98e0800445</gtr:id><gtr:otherNames>Reis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5F46A2B3-6FDA-48AA-9BE7-2F53F9F3115E"><gtr:id>5F46A2B3-6FDA-48AA-9BE7-2F53F9F3115E</gtr:id><gtr:title>PTEN mediates Notch-dependent stalk cell arrest in angiogenesis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ff41851e1996c577ab45b6a5262e73ec"><gtr:id>ff41851e1996c577ab45b6a5262e73ec</gtr:id><gtr:otherNames>Serra H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/81B8641E-2225-46FC-AF66-C847DC489D12"><gtr:id>81B8641E-2225-46FC-AF66-C847DC489D12</gtr:id><gtr:title>Endothelial-Rac1 is not required for tumor angiogenesis unless alphavbeta3-integrin is absent.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ada9419bd4d36a9760d75b22472aaf98"><gtr:id>ada9419bd4d36a9760d75b22472aaf98</gtr:id><gtr:otherNames>D'Amico G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0CBE90C4-31D7-4A61-9D97-56F2DD49B3C3"><gtr:id>0CBE90C4-31D7-4A61-9D97-56F2DD49B3C3</gtr:id><gtr:title>Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fa994fc68a5b734ae12ea6fced112104"><gtr:id>fa994fc68a5b734ae12ea6fced112104</gtr:id><gtr:otherNames>Yokoyama M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D313C598-E1DD-4EAC-BFB2-8DF7F55A05E6"><gtr:id>D313C598-E1DD-4EAC-BFB2-8DF7F55A05E6</gtr:id><gtr:title>Wnt/beta-catenin signaling controls development of the blood-brain barrier.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3ef0bf4f5f6fa28f6083135e7efc6463"><gtr:id>3ef0bf4f5f6fa28f6083135e7efc6463</gtr:id><gtr:otherNames>Liebner S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EE47AD38-3039-42DD-A3AD-20FA420A1871"><gtr:id>EE47AD38-3039-42DD-A3AD-20FA420A1871</gtr:id><gtr:title>The ubiquitin ligase PDZRN3 is required for vascular morphogenesis through Wnt/planar cell polarity signalling.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cae6f7b64f6ea81b60bb6d003be18b89"><gtr:id>cae6f7b64f6ea81b60bb6d003be18b89</gtr:id><gtr:otherNames>Sewduth RN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501711</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>